Cargando…
Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA
The TSH receptor (TSHR) is the critical target for antibody production in Graves' disease (GD). Insulin-like growth factor 1 receptor (IGF1R) has been proposed as a second autoantigen in complications of GD such as orbitopathy. We attempted to induce orbital tissue remodeling in mice undergoing...
Autores principales: | Zhao, Shuang-Xia, Tsui, Shanli, Cheung, Anthony, Douglas, Raymond S, Smith, Terry J, Banga, J Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioScientifica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152291/ https://www.ncbi.nlm.nih.gov/pubmed/21715431 http://dx.doi.org/10.1530/JOE-11-0162 |
Ejemplares similares
-
Nuclear Targeting of IGF-1 Receptor in Orbital Fibroblasts from Graves' Disease: Apparent Role of ADAM17
por: Hoa, Neil, et al.
Publicado: (2012) -
Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2020) -
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy
por: Diana, T., et al.
Publicado: (2021) -
Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease
por: Cho, Won Yong, et al.
Publicado: (1988) -
Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves’ Disease
por: Inaba, Hidefumi, et al.
Publicado: (2016)